Log in

Relevant bibliographies by topics / Mechanism of action / Journal articles

Journal articles on the topic 'Mechanism of action'

To see the other types of publications on this topic, follow the link: Mechanism of action.

Author: Grafiati

Published: 4 June 2021

Last updated: 29 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Mechanism of action.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Dubey, Bidhyut Kumar, Mohini Chaurasia, and Jyoti Yadav. "ACTIVE CHEMICAL CONSTITUENTS FROM MEDICINAL PLANTS AND MECHANISM OF ACTION AS ANTIPARKINSONIAN." Era's Journal of Medical Research 7, no. 1 (June 2020): 120–25. http://dx.doi.org/10.24041/ejmr2019.120.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Dubey, Bidhyut Kumar, Mohini Chaurasia, and Jyoti Yadav. "ACTIVE CHEMICAL CONSTITUENTS FROM MEDICINAL PLANTS AND MECHANISM OF ACTION AS ANTIPARKINSONIAN." Era's Journal of Medical Research 7, no. 1 (June 2020): 120–25. http://dx.doi.org/10.24041/ejmr2020.20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Edwards, David I. "Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action." Journal of Antimicrobial Chemotherapy 31, no. 1 (1993): 9–20. http://dx.doi.org/10.1093/jac/31.1.9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Zhong, Shan, Jeong Woo Choi, Nadia G. Hashoush, Diana Babayan, Mahsa Malekmohammadi, Nader Pouratian, and Vassilios Christopoulos. "A neurocomputational theory of action regulation predicts motor behavior in neurotypical individuals and patients with Parkinson’s disease." PLOS Computational Biology 18, no. 11 (November 17, 2022): e1010111. http://dx.doi.org/10.1371/journal.pcbi.1010111.

Full text

Abstract:

Surviving in an uncertain environment requires not only the ability to select the best action, but also the flexibility to withhold inappropriate actions when the environmental conditions change. Although selecting and withholding actions have been extensively studied in both human and animals, there is still lack of consensus on the mechanism underlying these action regulation functions, and more importantly, how they inter-relate. A critical gap impeding progress is the lack of a computational theory that will integrate the mechanisms of action regulation into a unified framework. The current study aims to advance our understanding by developing a neurodynamical computational theory that models the mechanism of action regulation that involves suppressing responses, and predicts how disruption of this mechanism can lead to motor deficits in Parkinson’s disease (PD) patients. We tested the model predictions in neurotypical individuals and PD patients in three behavioral tasks that involve free action selection between two opposed directions, action selection in the presence of conflicting information and abandoning an ongoing action when a stop signal is presented. Our results and theory suggest an integrated mechanism of action regulation that affects both action initiation and inhibition. When this mechanism is disrupted, motor behavior is affected, leading to longer reaction times and higher error rates in action inhibition.

APA, Harvard, Vancouver, ISO, and other styles

5

Kubala Havrdová, Eva. "Cladribine - mechanism of action." Neurologie pro praxi 18, Suppl.F (December 1, 2017): 5–8. http://dx.doi.org/10.36290/neu.2017.122.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Rodan, Gideon, and Alfred Reszka. "Bisphosphonate Mechanism of Action." Current Molecular Medicine 2, no. 6 (September 1, 2002): 571–77. http://dx.doi.org/10.2174/1566524023362104.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

KASUGA, Masato. "Mechanism of Insulin Action." Folia Endocrinologica Japonica 69, no. 10 (1993): 1029–34. http://dx.doi.org/10.1507/endocrine1927.69.10_1029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Hurtley, Stella M. "ISRIB mechanism of action." Science 359, no. 6383 (March 29, 2018): 1480.8–1481. http://dx.doi.org/10.1126/science.359.6383.1480-h.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Weiner, George J. "Rituximab: Mechanism of Action." Seminars in Hematology 47, no. 2 (April 2010): 115–23. http://dx.doi.org/10.1053/j.seminhematol.2010.01.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fuller, Ray W., Charles M. Beasley, Robert A. King, George M. Anderson, Ann Rasmusson, and Mark A. Riddle. "Fluoxetine Mechanism of Action." Journal of the American Academy of Child & Adolescent Psychiatry 30, no. 5 (September 1991): 849. http://dx.doi.org/10.1097/00004583-199109000-00030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

King, Robert A., George M. Anderson, Ann Rasmusson, and Mark A. Riddle. "Fluoxetine Mechanism of Action." Journal of the American Academy of Child & Adolescent Psychiatry 30, no. 5 (September 1991): 849. http://dx.doi.org/10.1097/00004583-199109000-00031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Espinal, Joe. "Mechanism of insulin action." Nature 328, no. 6131 (August 1987): 574–75. http://dx.doi.org/10.1038/328574a0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Fuller, Ray W., and Charles M. Beasley. "Fluoxetine mechanism of action." Journal of the American Academy of Child & Adolescent Psychiatry 30, no. 5 (September 1991): 849. http://dx.doi.org/10.1016/s0890-8567(10)80032-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Marians, Kenneth J., and Hiroshi Hiasa. "Mechanism of Quinolone Action." Journal of Biological Chemistry 272, no. 14 (April 4, 1997): 9401–9. http://dx.doi.org/10.1074/jbc.272.14.9401.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Drlica, Karl. "Mechanism of fluoroquinolone action." Current Opinion in Microbiology 2, no. 5 (October 1999): 504–8. http://dx.doi.org/10.1016/s1369-5274(99)00008-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Weller, Stephen C. "Herbicide Mechanism of Action." Weed Science 39, no. 3 (September 1991): 427. http://dx.doi.org/10.1017/s0043174500073185.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Zhanel, George G., Frank Schweizer, and James A. Karlowsky. "Oritavancin: Mechanism of Action." Clinical Infectious Diseases 54, suppl_3 (April 15, 2012): S214—S219. http://dx.doi.org/10.1093/cid/cir920.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Baudrand, Rene, Luminita H. Pojoga, Jose R. Romero, and Gordon H. Williams. "Aldosteroneʼs mechanism of action." Current Opinion in Nephrology and Hypertension 23, no. 1 (January 2014): 32–37. http://dx.doi.org/10.1097/01.mnh.0000436543.48391.e0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Trabalzini, Lorenza. "Khellin: Mechanism of action." Journal of Photochemistry and Photobiology B: Biology 9, no. 3-4 (June 1991): 403–4. http://dx.doi.org/10.1016/1011-1344(91)80198-q.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Reszka, Alfred A., and Gideon A. Rodan. "Bisphosphonate mechanism of action." Current Rheumatology Reports 5, no. 1 (January 2003): 65–74. http://dx.doi.org/10.1007/s11926-003-0085-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

ORTEGA, LAURA G., MATTHEW D. MCCOTTER, GILBERT L. HENRY, STEPHEN J. MCCORMACK, DANIEL C. THOMIS, and CHARLES E. SAMUEL. "Mechanism of Interferon Action." Virology 215, no. 1 (January 1996): 31–39. http://dx.doi.org/10.1006/viro.1996.0004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Borchardt, Ronald T. "Mechanism of Drug Action." Journal of Pharmaceutical Sciences 74, no. 8 (August 1985): 910. http://dx.doi.org/10.1002/jps.2600740841.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Ali, Ghorbat Saleh. "Mechanism of Action p53." Asian Pacific Journal of Cancer Biology 8, no. 1 (March 2, 2023): 63–68. http://dx.doi.org/10.31557/apjcb.2023.8.1.63-68.

Full text

Abstract:

P53 is a 393 residue protein in humans made up of five proposed domains, with which the central DNA binding domain with 100-300 sequences very important for the direct binding of p53 in the promoters of its target genes to specific response elements. P53 is a tumor suppressor gene with cellular stress like oxygen deficiency, oxidative stress, radiation and carcinogens substances, is stimulated has major roles in translational regulation and feedback processes. A wide variety of damage signals that relate to the stability, post-translational alteration and recruitment of p53 to binding sites in chromatin which activate the p53 pathway. As a transcriptional activation, p53 mediates transcriptional changes which facilitate cell death, senescence or reversing and protective arrest of the cell cycle. P53 is a protein under intense investigation because it is necessary to prevent tumor, in human tumors have been found to deregulation of p53 activity. On this article study focuses the mechanism of suppressive p53 effects in the response to any stress and correlation of the mutation p53 with different tumor.

APA, Harvard, Vancouver, ISO, and other styles

24

Ali, Ghorbat, and Basim Ahmed. "Mechanism of Action p53." Egyptian Journal of Veterinary Sciences 54, no. 5 (November 1, 2023): 941–48. http://dx.doi.org/10.21608/ejvs.2023.205434.1490.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Berry, Marla J., and Charles E. Samuel. "Mechanism of interferon action." Biochemical and Biophysical Research Communications 133, no. 1 (November 1985): 168–75. http://dx.doi.org/10.1016/0006-291x(85)91856-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Wuttke, Wolfgang, Hubertus Jarry, and Dana Seidlovα-Wuttke. "Definition, classification and mechanism of action of endocrine disrupting chemicals." HORMONES 9, no. 1 (January 15, 2010): 15. http://dx.doi.org/10.14310/horm.2002.1252.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Goddette, D. W., and C. Frieden. "Actin polymerization. The mechanism of action of cytochalasin D." Journal of Biological Chemistry 261, no. 34 (December 1986): 15974–80. http://dx.doi.org/10.1016/s0021-9258(18)66662-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Greene, Stephen J., and Mihai Gheorghiade. "Matching Mechanism of Death With Mechanism of Action." Journal of the American College of Cardiology 64, no. 15 (October 2014): 1599–601. http://dx.doi.org/10.1016/j.jacc.2014.06.1199.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Brin, Mitchell F., and Rami Burstein. "Botox (onabotulinumtoxinA) mechanism of action." Medicine 102, S1 (July 1, 2023): e32372. http://dx.doi.org/10.1097/md.0000000000032372.

Full text

Abstract:

Studies in the 1920s found that botulinum neurotoxin type A (BoNT/A) inhibited the activity of motor and parasympathetic nerve endings, confirmed several decades later to be due to decreased acetylcholine release. The 1970s were marked by studies of cellular mechanisms aided by use of neutralizing antibodies as pharmacologic tools: BoNT/A disappeared from accessibility to neutralizing antibodies within minutes, although it took several hours for onset of muscle weakness. The multi-step mechanism was experimentally confirmed and is now recognized to consist broadly of binding to nerve terminals, internalization, and lysis or cleavage of a protein (SNAP-25: synaptosomal associated protein-25 kDa) that is part of the SNARE (Soluble NSF Attachment protein REceptor) complex needed for synaptic vesicle docking and fusion. Clinical use of the BoNT/A product onabotulinumtoxinA was based on its ability to reduce muscle contractions via inhibition of acetylcholine from motor terminals. Sensory mechanisms of onabotulinumtoxinA have now been identified, supporting its successful treatment of chronic migraine and urgency in overactive bladder. Exploration into migraine mechanisms led to anatomical studies documenting pain fibers that send axons through sutures of the skull to outside the head—a potential route by which extracranial injections could affect intracranial processes. Several clinical studies have also identified benefits of onabotulinumtoxinA in major depression, which have been attributed to central responses induced by feedback from facial muscle and skin movement. Overall, the history of BoNT/A is distinguished by basic science studies that stimulated clinical use and, conversely, clinical observations that spurred basic research into novel mechanisms of action.

APA, Harvard, Vancouver, ISO, and other styles

30

Hirabayashi, Yoko, and Tohru Inoue. "Endocrine Disruptors: Mechanism of Action." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 35, no. 12 (1998): 873–79. http://dx.doi.org/10.3143/geriatrics.35.873.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Wallmark, Björn. "Mechanism of Action of Omeprazole." Scandinavian Journal of Gastroenterology 21, sup118 (January 1986): 11–16. http://dx.doi.org/10.3109/00365528609090881.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Hemaiswarya, S., R. Raja, R. Ravikumar, and Isabel S. Carvalho. "Mechanism of action of probiotics." Brazilian Archives of Biology and Technology 56, no. 1 (February 2013): 113–19. http://dx.doi.org/10.1590/s1516-89132013000100015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Paolucci, Francis, Marie-Christine Clavi??s, Fran??ois Donat, and Jos?? Necciari. "Fondaparinux Sodium Mechanism of Action." Clinical Pharmacokinetics 41, Supplement 2 (2002): 11–18. http://dx.doi.org/10.2165/00003088-200241002-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Seeman, Philip. "Atypical Antipsychotics: Mechanism of Action." FOCUS 2, no. 1 (January 2004): 48–58. http://dx.doi.org/10.1176/foc.2.1.48.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Luyts, N., H. De Bruyn, T. Voets, and W. Everaerts. "Mechanism of action of Phenazopyridine." European Urology 81 (February 2022): S16—S17. http://dx.doi.org/10.1016/s0302-2838(22)00101-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Du, Guangqian, Shijie Wang, and Jichao Chu. "Mechanism of Action Slope Vegetation." Advance Journal of Food Science and Technology 11, no. 12 (August 25, 2016): 805–9. http://dx.doi.org/10.19026/ajfst.11.2796.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Millichap, J. Gordon. "Ketogenic Diet Mechanism of Action." Pediatric Neurology Briefs 10, no. 4 (April 1, 1996): 27. http://dx.doi.org/10.15844/pedneurbriefs-10-4-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Fox, E. J. "Mechanism of action of mitoxantrone." Neurology 63, Issue 12, Supplement 6 (December 28, 2004): S15—S18. http://dx.doi.org/10.1212/wnl.63.12_suppl_6.s15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Smith, Charles D., and Xinqun Zhang. "Mechanism of Action of Cryptophycin." Journal of Biological Chemistry 271, no. 11 (March 15, 1996): 6192–98. http://dx.doi.org/10.1074/jbc.271.11.6192.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Soriano, Alex, and Josep Mensa. "Mechanism of action of cefiderocol." Revista Española de Quimioterapia 35, Suppl2 (October 4, 2022): 16–19. http://dx.doi.org/10.37201/req/s02.02.2022.

Full text

Abstract:

Gram-negative bacilli are intrinsically resistant to many antibiotics due to the low permeability of their outer membrane. The most effective strategy to solve this problem has been the design of antibiotics that cross the membrane using specific transport systems. This is the case of cefiderocol, which, unlike cefepime or ceftazidime, has a chlorocatechol group at the end of the C-3 side chain. This group is recognized by transporters located in the outer membrane that allow cefiderocol to accumulate in the periplasmic space. Furthermore, cefiderocol is not a substrate for efflux pumps and the configuration of the side chains at C-7 and in particular at C-3 confer it a high stability against hydrolysis by most beta-lactamases of clinical interest including class A (KPC, BLEEs), C (ampC) or D (OXA-48) serine beta-lactamases and metallo-betalactamases (NDM, VIM. IMP). In order to better understand the mechanism of action of cefiderocol, the importance of iron in bacterial metabolism and the competition for iron between bacteria and host are reviewed.

APA, Harvard, Vancouver, ISO, and other styles

41

Garlid, K. D., M. Jaburek, and P. Jezek. "Mechanism of uncoupling protein action." Biochemical Society Transactions 29, no. 6 (November 1, 2001): 803–6. http://dx.doi.org/10.1042/bst0290803.

Full text

Abstract:

Two competing models of uncoupling protein (UCP) transport mechanism agree that fatty acids (FAs) are obligatory for uncoupling, but they disagree about which ion is transported. In Klingenberg's model, UCPs conduct protons. In Garlid's model, UCPs conduct anions, like all members of this gene family. In the latter model, UCP transports the anionic FA head group from one side of the membrane to the other, and the cycle is completed by rapid flip-flop of protonated FAs across the bilayer. The head groups of the FA analogues, long-chain alkylsulphonates, are translocated by UCP, but they cannot induce uncoupling, because these strong acids cannot be protonated for the flip-flop part of the cycle. We have overcome this limitation by ion-pair transport of undecanesulphonate with propranolol, which causes the sulphonate to deliver protons across the membrane as if it were an FA. Full GDP-sensitive uncoupling is seen in the presence of propranolol and undecanesulphonate. This result confirms that the mechanism of UCP uncoupling requires transport of the anionic FA head group by UCP and that the proton transport occurs via the bilayer and not via UCP.

APA, Harvard, Vancouver, ISO, and other styles

42

Garlid, K. D., M. Jaburek, and P. Jezek. "Mechanism of uncoupling protein action." Biochemical Society Transactions 29, no. 5 (October 1, 2001): A100. http://dx.doi.org/10.1042/bst029a100b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Goodwin, G. M. "Mechanism of action of lithium." Current Opinion in Psychiatry 1, no. 1 (January 1988): 72–75. http://dx.doi.org/10.1097/00001504-198801000-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Goodwin, G. M. "Mechanism of action of lithium." Current Opinion in Psychiatry 2, no. 1 (February 1989): 117–18. http://dx.doi.org/10.1097/00001504-198902000-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Graham, Garry G., and Kieran F. Scott. "Mechanism of Action of Paracetamol." American Journal of Therapeutics 12, no. 1 (January 2005): 46–55. http://dx.doi.org/10.1097/00045391-200501000-00008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

CREASEY, N. H., A. C. ALLENBY, and C. SCHOCK. "MECHANISM OF ACTION OF ACCELERANTS." British Journal of Dermatology 85, no. 4 (July 29, 2006): 368–80. http://dx.doi.org/10.1111/j.1365-2133.1971.tb14032.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

LIU, LEROY F., SHYAMAL D. DESAI, TSAI-KUN LI, YONG MAO, MEI SUN, and SAI-PENG SIM. "Mechanism of Action of Camptothecin." Annals of the New York Academy of Sciences 922, no. 1 (January 25, 2006): 1–10. http://dx.doi.org/10.1111/j.1749-6632.2000.tb07020.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Piddock, L. J., M. C. Hall, and R. Wise. "Mechanism of action of lomefloxacin." Antimicrobial Agents and Chemotherapy 34, no. 6 (June 1, 1990): 1088–93. http://dx.doi.org/10.1128/aac.34.6.1088.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Disis, Mary L. "Mechanism of Action of Immunotherapy." Seminars in Oncology 41 (October 2014): S3—S13. http://dx.doi.org/10.1053/j.seminoncol.2014.09.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Haskett, Roger F. "Electroconvulsive Therapy’s Mechanism of Action." Journal of ECT 30, no. 2 (June 2014): 107–10. http://dx.doi.org/10.1097/yct.0000000000000143.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!